Medical Management of Pump-Related Thrombosis in Patients with Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-Analysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  ASAIO journal (1992)

• Publication date

  2017-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MAT.0000000000000497PMID 27984314PMCID PMC5468512
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Outcomes of Various Treatment Strategies for Patients with Continuous-Flow Ventricular Assist Device Thrombosis: A Retrospective Analysis

  2016cited by this paper
• Diagnosis and Treatment Algorithm for Blood Flow Obstructions in Patients With Left Ventricular Assist Device.

  2016cited by this paper
• Non-obstructive left ventricular assist device outflow thrombus: What is the appropriate management?

  2016cited by this paper
• Ticagrelor for left ventricular assist device thrombosis: A new therapeutic option to be evaluated with caution.

  2016cited by this paper
• Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: An attempt to avoid reoperation

  2016cited by this paper
• Systemic Thrombolysis Versus Device Exchange for Pump Thrombosis Management: A Single-Center Experience

  2016cited by this paper
• Conservative approaches for HeartWare ventricular assist device pump thrombosis may improve the outcome compared with immediate surgical approaches.

  2016cited by this paper
• Incidence, Management, and Outcome of Suspected Continuous-Flow Left Ventricular Assist Device Thrombosis

  2016cited by this paper
• Should device replacement be the first choice strategy in continuous-flow left ventricle assist device thrombosis? Analysis of 9 events and results after endoventricular thrombolysis.

  2015cited by this paper
• Successful treatment of acute left ventricular assist device thrombosis and cardiogenic shock with intraventricular thrombolysis and a tandem heart.

  2015cited by this paper
• Antithrombotic therapy for left ventricular assist devices in adults: a systematic review

  2015cited by this paper
• Thrombosis in Continuous‐Flow Left Ventricular Assist Devices: Pathophysiology, Prevention, and Pharmacologic Management

  2015cited by this paper
• Diagnosis, Nonsurgical Management, and Prevention of LVAD Thrombosis

  2014cited by this paper
• The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.

  2014cited by this paper
• HeartWare left ventricular assist device thrombosis in aspirin non-responder

  2014cited by this paper
• An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.

  2014cited by this paper
• Left coronary artery occlusion caused by a large thrombus on the left coronary cusp in a patient with a continuous-flow ventricular assist device

  2014cited by this paper
• Argatroban as novel therapy for suspected thrombosis in patients with continuous-flow left ventricle assist device and hemolysis.

  2014cited by this paper
• Left ventricular assist device thrombosis presenting as an acute coronary syndrome.

  2014cited by this paper
• Left Ventricular Assist Device Pump Thrombosis: Is There a Role for Glycoprotein IIb/IIIa Inhibitors?

  2014cited by this paper
• Successful repeated thrombolysis in a patient with HeartWare thrombosis – the importance of Doppler flow pattern

  2014cited by this paper
• Bivalirudin for Treatment of LVAD Thrombosis: A Case Series

  2014cited by this paper
• Thrombolytic therapy for thrombosis of continuous flow ventricular assist devices.

  2014cited by this paper
• HeartWare left ventricular assist device thrombosis including outflow graft.

  2014cited by this paper
• The Role of Medical Management for Acute Intravascular Hemolysis in Patients Supported on Axial Flow LVAD

  2014cited by this paper
• Continuous flow left ventricular assist device placement complicated by aortic valve thrombus and myocardial infarction.

  2014cited by this paper
• Unexpected abrupt increase in left ventricular assist device thrombosis.

  2014cited by this paper
• Device exchange after primary left ventricular assist device implantation: indications and outcomes.

  2013cited by this paper
• Direct Thrombolytic Therapy for Thrombosis of a Centrifugal Flow Left Ventricular Assist Device

  2013cited by this paper
• Bivalirudin for treatment of aortic valve thrombosis after left ventricular assist device implantation.

  2013cited by this paper
• Thrombolysis for suspected intrapump thrombosis in patients with continuous flow centrifugal left ventricular assist device.

  2013cited by this paper
• Nonoperative management of aortic valve thrombus in a patient with left ventricular assist device.

  2013cited by this paper
• Treatment of left ventricular assist device thrombosis with extended catheter-directed intraventricular thrombolytic therapy.

  2013cited by this paper
• Comparing Survival of HMII Patients with Elevated LDH: Implications for Medical and Surgical Management

  2013cited by this paper
• Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality.

  2013cited by this paper
• Detection of carboxyhemefibrinogen and methemefibrinogen in a patient with thrombosis of a HeartMate II ventricular assist device.

  2013cited by this paper
• Algorithm for the diagnosis and management of suspected pump thrombus.

  2013cited by this paper
• Failed repeated thrombolysis requiring left ventricular assist device pump exchange

  2013cited by this paper
• Successful treatment of a continuous flow left ventricular assist device thrombosis with eptifibatide.

  2012cited by this paper
• Implantation of left ventricular assist device complicated by undiagnosed thrombophilia.

  2012cited by this paper
• Use of an Intrapericardial, Continuous-Flow, Centrifugal Pump in Patients Awaiting Heart Transplantation

  2012cited by this paper
• Can Learning to Interpret Pump Messages Help Lead to an Early Diagnosis of HeartWare Ventricular Assist Device Thrombosis?

  2012cited by this paper
• HeartWare continuous-flow ventricular assist device thrombosis: the Bad Oeynhausen experience.

  2012cited by this paper
• Successful treatment of early thrombosis of HeartWare left ventricular assist device with intraventricular thrombolytics.

  2012cited by this paper
• Eptifibatide for the treatment of HeartMate II left ventricular assist device thrombosis.

  2012cited by this paper
• Novel application of angiojet rheolytic thrombectomy for massive thrombosis of the native aortic valve and jarvick 2000 ventricular assist device in a patient with end‐stage heart failure

  2011cited by this paper
• Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics.

  2011cited by this paper
• Aortic root and valve thrombosis after implantation of a left ventricular assist device.

  2011cited by this paper
• Images in cardiovascular medicine. Repeated successful thrombolysis of a Jarvik 2000 left ventricular assist device in a patient with noncompaction cardiomyopathy.

  2010cited by this paper
• Conducting Meta-Analyses in R with the metafor Package

  2010cited by this paper
• Random effects meta‐analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data

  2010cited by this paper
• Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

  2010cited by this paper
• Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association

  2009cited by this paper
• Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.

  2009cited by this paper
• Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement

  2009cited by this paper
• Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

  2009cited by this paper
• Advanced heart failure treated with continuous-flow left ventricular assist device.

  2009cited by this paper
• Successful treatment of ventricular assist device associated ventricular thrombus with systemic tenecteplase.

  2008cited by this paper
• Profound thrombocytopenia with glycoprotein IIb/IIIa inhibitors plus heparin for pump thrombus.

  2008cited by this paper
• Thrombus formation in a HeartMate II left ventricular assist device.

  2008cited by this paper
• Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban.

  2008cited by this paper
• Successful fibrinolysis after acute left ventricular assist device thrombosis.

  2007cited by this paper
• Recurrent device thrombi during mechanical circulatory support with an axial-flow pump is a treatable condition and does not preclude successful long-term support.

  2007cited by this paper
• Long-term support of 9 patients with the DeBakey VAD for more than 200 days.

  2005cited by this paper
• Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device.

  2005cited by this paper
• Successful intraventricular thrombolysis during ventricular assist device support.

  2002cited by this paper
• Treatment of Thrombus Formation Associated With the MicroMed DeBakey VAD Using Recombinant Tissue Plasminogen Activator

  2002cited by this paper
• Long-term use of a left ventricular assist device for end-stage heart failure.

  2001cited by this paper
• Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children.

  1998cited by this paper

• Structural Heart Interventions in Patients with Left Ventricular Assist Devices

  2025cites this paper
• An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device.

  2024cites this paper
• Left Ventricular Assist Device Emergencies: Diagnosis and Management.

  2023cites this paper
• Emergent left ventricular assist device decommissioning in the setting of impending pump shutdown in heart transplant candidate

  2023cites this paper
• Characterization of Shear Stress Mediated Platelet Dysfunction: Data from an Ex Vivo Model for Extracorporeal Circulation and a Prospective Clinical Study

  2023cites this paper
• Alexandar Gerogianni-omslag.indd

  2023cites this paper
• Hemocompatibility and Biophysical Interface of Left Ventricular Assist Devices and Total Artificial Hearts.

  2023cites this paper
• Coronavirus disease 2019 and mechanical circulatory support devices: A comprehensive review.

  2022cites this paper
• Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation

  2022influential citation
• Accelerated LVAD pump thrombosis in COVID‐19 patient: Case report and mini review

  2022influential citation
• Long-Term Ventricular Assist Devices – Main Complications in Contemporary Clinical Practice

  2022cites this paper
• Přehledový článek | Review article Fyziologie léčby levostrannými mechanickými srdečními podporami s kontinuálním tokem. Překlad dokumentu připravený Českou kardiologickou společností (Physiology of Continuous-fl ow Left Ventricular Assist Device Therapy. Translation of the document

  2022cites this paper
• Reproductive health after thoracic transplantation: An ISHLT expert consensus statement.

  2022cites this paper
• LVAD as a bridge to decision complicated with pump thrombosis and infection

  2021cites this paper
• A novel protocol to reduce bleeding associated with alteplase treatment of HVAD pump thrombosis

  2021cites this paper
• Hemostatic Challenges in Pediatric Critical Care Medicine—Hemostatic Balance in VAD

  2021cites this paper
• ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association.

  2021cites this paper
• Physiology of Continuous-Flow Left Ventricular Assist Device Therapy.

  2021cites this paper
• Characterization of Shear Stress Mediated Platelet Dysfunction: Data from an Ex Vivo Model for Extracorporeal Circulation and a Prospective Clinical Study

  2021cites this paper
• Left Ventricular Assist Device Thrombosis Treated with Intravenous Tissue Plasminogen Activator in a Patient with COVID-19 Infection

  2021cites this paper
• Invasive Haemodynamic Assessment Before and After Left Ventricular Assist Device Implantation: A Guide to Current Practice

  2021cites this paper
• Antiplatelet and anticoagulation strategies for left ventricular assist devices

  2020cites this paper
• Clinical Implications of LDH Isoenzymes in Hemolysis and Continuous-flow Left Ventricular Assist Device-Induced Thrombosis.

  2020cites this paper
• Spleen size improvement in advanced heart failure patients using a left ventricular assist device.

  2020cites this paper
• Reviewing the clinical utility of ventricular assist device log files

  2020cites this paper
• Limited Efficacy of Thrombolytics for Pump Thrombosis in Durable Left Ventricular Assist Devices.

  2020cites this paper
• Review and reflections about pulsatile ventricular assist devices from history to future: concerning safety and low haemolysis—still needed

  2020cites this paper
• Cardiac Emergencies in Patients with Left Ventricular Assist Devices.

  2020cites this paper
• Pulsatility in ventricular assistance devices: A translational review focused on applied haemodynamics.

  2020cites this paper
• Comprehensive review of hemolysis in ventricular assist devices

  2020cites this paper
• Cangrelor: Safe and Effective for Left Ventricular Assist Device Thrombosis

  2020cites this paper
• Thrombolysis as first-line therapy for Medtronic/HeartWare HVAD left ventricular assist device thrombosis.

  2020cites this paper
• Medical and Invasive Management of Cardiac Thrombosis in Children with Congenital and Acquired Heart Disease

  2020cites this paper
• Pharmacotherapy for durable left ventricular assist devices

  2020cites this paper
• Synergistic effect of shear and ADP on platelet growth on ZTA and Ti6Al4V surfaces.

  2020cites this paper
• Varying speed modulation of continuous-flow left ventricular assist device based on cardiovascular coupling numerical model

  2020cites this paper
• Medical Management of Recurrent Left Ventricular Assist Device Thrombosis in a Patient With Biventricular Assist Devices

  2020cites this paper
• Intraoperative pump thrombosis (PT) in HeartMate (HM) III

  2020cites this paper
• World Journal of Cardiology MicroRNA sequences modulating inflammation and lipid accumulation in macrophage “foam” cells: Implications for atherosclerosis MINIREVIEWS

  2020cites this paper
• Early Outcomes with Durable Left Ventricular Assist Device Replacement Utilizing the Heartmate III

  2020cites this paper
• LVAD Woes: Lub-Dub, Lub-Dub, Lub-Dub…or Maybe Not!

  2019cites this paper
• Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin

  2019cites this paper
• Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.

  2019cites this paper
• Massive retroperitoneal hemorrhage after external shock wave lithotripsy in a patient with a left ventricular assist device

  2019cites this paper
• Left ventricular assist device diagnostics using controller log files: The potential for predictive algorithms?

  2019cites this paper
• Log files analysis and evaluation of circadian patterns for the early diagnosis of pump thrombosis with a centrifugal continuous-flow left ventricular assist device.

  2019cites this paper
• Management of RVAD Thrombosis in Biventricular HVAD Supported Patients: Case Series

  2019cites this paper
• Tranzitorni signali visokog intenziteta u bolesnika s ugrađenim cirkulacijskim crpkama

  2019cites this paper
• Heart Transplantation in the Era of the Left Ventricular Assist Devices

  2018cites this paper
• State of the Art Review: Evolution and Ongoing Challenges of Left Ventricular Assist Device Therapy

  2018cites this paper
• Adult and pediatric mechanical circulation: a guide for the hematologist.

  2018cites this paper
• Bivalirudin for left ventricular assist device thrombosis

  2018cites this paper
• Effective strategy of rescue treatment for acute pump thrombosis after left ventricular assist device implantation in patients with high risk of bleeding complications.

  2018cites this paper
• Clinical Relevance of Histopathologic Analysis of HeartMate II Thrombi

  2018cites this paper
• Antithrombotic therapy in ventricular assist device (VAD) management: From ancient beliefs to updated evidence. A narrative review☆

  2018cites this paper
• Anticoagulation with VADs and ECMO: walking the tightrope.

  2017cites this paper
• Outflow Graft Occlusion of the HeartMate 3 Left Ventricular Assist Device.

  2017cites this paper
• Intravenous thrombolytic therapy for patients with ventricular assist device thrombosis: An attempt to avoid reoperation

  2016cites this paper